ArticleOpen forum infectious diseases2025

Aztreonam-avibactam Demonstrates Potent Activity Against Carbapenem-resistant Enterobacterales Collected From US Medical Centers Over a 6-year Period (2017-2022).

Krisztina M Papp-Wallace et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.